17β-Estradiol inhibits osteoprotegerin production by the estrogen receptor-α-positive human breast cancer cell line MCF-7

This publication has 21 references indexed in Scilit:

• Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours
  Journal of Clinical Pathology, 2006
• Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
  JAMA, 2004
• Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women
  Clinical Endocrinology, 2003
• Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
  Journal of Clinical Investigation, 2003
• Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
  New England Journal of Medicine, 2003
• The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts
  Bone, 2003
• Differential Gene Expression of TGF-β Family Members and Osteopontin in Breast Tumor Tissue: Analysis by Real-Time Quantitative PCR
  Breast Cancer Research and Treatment, 2002
• Mechanisms in the skeletal complications of breast cancer.
  Endocrine-Related Cancer, 2000
• Estrogen Stimulates Gene Expression and Protein Production of Osteoprotegerin in Human Osteoblastic Cells*
  Endocrinology, 1999
• Mechanisms of bone metastasis
  Cancer, 1997